Search

Embecta Corp

Geschlossen

BrancheGesundheitswesen

6.45 0.47

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

6.36

Max

6.45

Schlüsselkennzahlen

By Trading Economics

Einkommen

25M

21M

Verkäufe

50M

272M

KGV

Branchendurchschnitt

4.361

68.089

EPS

0.56

Dividendenrendite

7.43

Gewinnspanne

7.766

Angestellte

1,850

EBITDA

20M

65M

Dividenden

By Acuity

Dividendenrendite

Branchendurchschnitt

7.43%

1.98%

Nächstes Ergebnis

24. Nov. 2026

Nächste Dividendenausschüttung

17. Dez. 2026

Nächstes Ex-Dividendendatum

4. Dez. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

142M

363M

Vorheriger Eröffnungskurs

5.98

Vorheriger Schlusskurs

6.45

Embecta Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

13. Nov. 2026, 22:41 UTC

Embecta Corp. is trading lower in after-market hours, reflecting broader market declines driven by Federal Reserve rate hike concerns and turmoil in the tech sector.

12. Nov. 2026, 21:02 UTC

News

Embecta Corp. is under investigation by Bronstein, Gewirtz & Grossman, LLC for potential corporate wrongdoing involving the company and its officers or directors.

11. Nov. 2026, 21:06 UTC

Embecta Corp. shares are trading higher, recovering from early lows to peak around midday, remaining above the 20-day moving average.

10. Nov. 2026, 20:46 UTC

News

Embecta Corp. is under investigation by Bronstein, Gewirtz & Grossman, LLC for potential corporate wrongdoing involving its officers and directors.

9. Nov. 2026, 23:31 UTC

Embecta Corp. is seeing a deeper decline in after-market trading, moving further below its 20-day moving average by session's end.

6. Nov. 2026, 21:07 UTC

Embecta Corp. shares fell sharply, continuing a decline from Thursday's close and remaining below the 20-day moving average.

5. Nov. 2026, 21:08 UTC

News

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Embecta Corp. over allegations of corporate wrongdoing involving its officers and directors.

4. Nov. 2026, 21:04 UTC

Embecta Corp. shares are sharply higher, marking a significant increase since Tuesday's close, despite broader market volatility earlier in the day.

3. Nov. 2026, 20:36 UTC

News

Embecta Corp. is under investigation by Bronstein, Gewirtz & Grossman, LLC, regarding potential corporate misconduct involving the company and its officers or directors.

2. Nov. 2026, 20:36 UTC

Embecta Corp. shares fell below Friday's close, fluctuating earlier in the session before retreating to the middle of its one-month range.

30. Okt. 2026, 20:03 UTC

Embecta Corp. shares fell sharply, facing significant selling pressure and reaching a cumulative return of approximately -4.73% since Thursday's close.

29. Okt. 2026, 20:02 UTC

Embecta Corp. shares are advancing notably during Thursday's session, currently positioned above its 20-day moving average and near the upper end of its one-month range.

27. Okt. 2026, 20:02 UTC

News

Embecta Corp. is under investigation by Bronstein, Gewirtz & Grossman, LLC for potential corporate wrongdoing claims involving its officers and directors.

26. Okt. 2026, 20:21 UTC

Embecta Corp shares declined modestly in after-market trading, falling from Monday's close and reaching the day's lowest point after a brief pause.

22. Okt. 2026, 20:04 UTC

Embecta Corp shares are notably higher, having pulled back from an earlier peak, but remain up compared to Wednesday's close amid strong recent performance.

21. Okt. 2026, 20:07 UTC

Embecta Corp shares are advancing, continuing a trend of gains since Tuesday's close, aligning with a broader market increase and positioned above its 20-day moving average.

20. Okt. 2026, 20:08 UTC

Embecta Corp shares are advancing, maintaining a position above their 20-day moving average amid a strong session for the health care supplies sector.

15. Okt. 2026, 20:02 UTC

Embecta Corp shares are trading sharply higher, continuing a strong performance and remaining near the upper end of their one-month range.

14. Okt. 2026, 19:46 UTC

Embecta Corp shares fell, reflecting a cumulative decline while remaining above its 20-day moving average and near the upper end of its one-month range.

13. Okt. 2026, 20:13 UTC

Embecta Corp's shares declined during after-market hours on Tuesday, maintaining a loss since the regular session close.

12. Okt. 2026, 23:06 UTC

Embecta Corp's shares advanced modestly higher in after-market trading, recovering from a low point earlier in the session while remaining above its 20-day moving average.

9. Okt. 2026, 19:35 UTC

Embecta Corp's shares are roughly flat, showing little change since Thursday's close, while positioned above its 20-day moving average.

8. Okt. 2026, 20:07 UTC

News

Embecta Corp is under investigation by Bronstein, Gewirtz & Grossman, LLC, regarding potential corporate wrongdoing involving its officers and directors.

7. Okt. 2026, 20:08 UTC

Embecta Corp shares fell modestly, retracing from a peak earlier in the day, but remain above their 20-day moving average.

6. Okt. 2026, 19:20 UTC

Embecta Corp is trading higher, supported by broader market gains and positive economic indicators, despite earlier pulling back from a session high.

5. Okt. 2026, 22:31 UTC

Embecta Corp is experiencing downward pressure in after-market trading, with losses accelerating since Monday's close while remaining above its 20-day moving average.

2. Okt. 2026, 23:20 UTC

Embecta Corp is seeing a notable decline in after-market trading, reaching its lowest cumulative return since Friday's close.

1. Okt. 2026, 20:07 UTC

Embecta Corp is advancing, remaining well above its previous close and significantly above its 20-day moving average, despite a slight pullback earlier in the session.

30. Sept. 2026, 20:02 UTC

Embecta Corp shares fell sharply after an early high, continuing a decline since Tuesday's close while remaining above the 20-day moving average.

29. Sept. 2026, 20:07 UTC

News

Embecta Corp shares are declining as Bronstein, Gewirtz & Grossman, LLC announced an investigation into potential corporate wrongdoing by the company's officers and directors.

Peer-Vergleich

Kursveränderung

Embecta Corp Prognose

Rating-Konsens

By TipRanks

Neutral

1 ratings

0

Buy

1

Halten

0

Sell

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Embecta Corp

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
help-icon Live chat